Avion Wealth’s Mineralys Therapeutics MLYS Stock Holding History

Avion Wealth’s Portfolio MLYS Stock Details MLYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-21	Closed	–	–	1585
2026 Q2	$0	Hold	21	–	–	﹤0.01%	1616
2026 Q1	$0	Hold	21	–	–	﹤0.01%	1464
2025 Q4	$0	Sell	21 -57	-73%	-$2.29K	﹤0.01%	1455
2025 Q3	$2K	Hold	78	–	–	﹤0.01%	878
2025 Q2	$1K	Hold	78	–	–	﹤0.01%	1013
2025 Q1	$0	Buy	+78	New	+$897	﹤0.01%	1234
2024 Q4	–	Sell	-78	Closed	–	–	1178
2024 Q3	$0	Hold	78	–	–	﹤0.01%	1213
2024 Q2	$0	Hold	78	–	–	﹤0.01%	1136
2024 Q1	$2K	Hold	78	–	–	﹤0.01%	720
2023 Q4	$1K	Buy	+78	New	+$612	﹤0.01%	874

Other funds holding MLYS

Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return

Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Avion Wealth's MLYS Position: Q3 2026 in Review

Avion Wealth sold out of Mineralys Therapeutics (MLYS) in Q3 2026, closing a stake of 21 shares.

Avion Wealth first reported a position in MLYS in Q4 2023 and held it in 10 quarters. The position peaked at $2K in Q3 2025. 51 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

Avion Wealth reported no remaining Mineralys Therapeutics position as of Q3 2026 after selling out during the quarter.
Avion Wealth sold 21 Mineralys Therapeutics shares in Q3 2026.
Avion Wealth first reported a position in Mineralys Therapeutics in Q4 2023 and held it in 10 quarters.
Avion Wealth's Mineralys Therapeutics position peaked at $2K in Q3 2025.
51 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.